Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes
- 1 April 2004
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 67 (7) , 1269-1278
- https://doi.org/10.1016/j.bcp.2003.11.010
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Stereospecific Interaction of a Novel Spirosuccinimide Type Aldose Reductase Inhibitor, AS-3201, with Aldose ReductaseBiochemistry, 2001
- Human UDP-Glucuronosyltransferases: Metabolism, Expression, and DiseaseAnnual Review of Pharmacology and Toxicology, 2000
- Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4 1 1Edited by J. KarnJournal of Molecular Biology, 2000
- Novel, Highly Potent Aldose Reductase Inhibitors: (R)-(−)-2-(4-Bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine- 4-spiro-3‘-pyrrolidine-1,2‘,3,5‘-tetrone (AS-3201) and Its CongenersJournal of Medicinal Chemistry, 1998
- The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergencePharmacogenetics, 1997
- High-performance liquid chromatographic analysis of phenobarbital and phenobarbital metabolites in human urineJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Gene Structure at the Human UGT1 Locus Creates Diversity in Isozyme Structure, Substrate Specificity, and RegulationProgress in Nucleic Acid Research and Molecular Biology, 1995
- Isolation of a Human YAC Contig Encompassing a Cluster of UGT2 Genes and Its Regional Localization to Chromosome 4q13Genomics, 1994
- Drug glucosidationPharmacology & Therapeutics, 1990
- N1-Glucosides as urinary metabolites of sulphadimidine, sulphamerazine and sulphamethoxazoleEuropean Journal of Drug Metabolism and Pharmacokinetics, 1988